AI-based analysis identifies the most impactful policy and resource factors for improving cancer survival across 185 countries.
Key Details
- 1Researchers used machine learning to analyze cancer incidence and mortality data from 185 countries.
- 2Study incorporated metrics on radiotherapy access, health system structure, and economic indicators.
- 3Radiotherapy access, universal health coverage, and national wealth repeatedly emerged as top factors for improved survival.
- 4The SHAP-based model provides country-specific roadmaps for policy investment priorities.
- 5An interactive tool allows users to view and compare readiness or gaps for their own country.
- 6The study is published in Annals of Oncology (Jan 2026).
Why It Matters
Radiotherapy access is a major imaging-related determinant of cancer outcomes globally; this AI-driven framework offers targeted, actionable guidance to policymakers and health leaders, promising more efficient allocation of imaging and treatment resources.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.